Blood Components Preparation
Introduction
-
Blood is
a mixture of cells, colloids, and crystalloids.
-
Can be
separated into different components:
-
Packed
Red Blood Cells (pRBC)
-
Platelet
Concentrate
-
Fresh
Frozen Plasma
-
Cryoprecipitate
Component Separation
Process
-
Components
separated based on:
-
Relative
density
-
Sediment
rate
-
Size
-
Centrifugal
force is applied for separation.
-
Each
component is used for specific indications.
Importance of Component
Separation
-
Maximizes
the utility of one whole blood unit.
-
Provides
different components for various therapeutic needs.
-
Enhances
efficiency and effectiveness of blood transfusions.
Storage and Temperature
Requirements
-
Different
components have specific storage conditions.
-
Temperature
requirements vary for therapeutic efficacy.
-
Proper
storage is crucial for maintaining component integrity.
Centrifuge Process
-
Two main
spins:
-
Heavy
spin (e.g., 5000 G for 10-15 min)
-
Light
spin (e.g., 1500 G for 5-7 min)
-
Configuration
varies with manufacturer and model.
Automated Component
Separation
-
Uses
fully automated separator instruments.
-
Prepares
low-volume blood components.
-
Achieves
90% recovery of whole blood platelets.
Red Cells Concentrate or
Packed Red Blood Cells (PRBCs)
-
Obtained
through centrifugation/sedimentation of whole blood.
-
Plasma is
transferred to a separate bag, leaving packed red cells behind.
-
Hematocrit
in packed red cell unit: 55% to 65%.
-
Reduced
volume (200 ml) decreases the risk of volume overload.
Characteristics and Storage
-
Each unit
raises hemoglobin concentration by 1 gm/dL.
-
Stored in
a refrigerator/cold room at 2°C to 4°C.
-
Shelf-life:
one month.
-
Essential
for managing anemia and restoring oxygen-carrying capacity.
Indications for PRBCs
-
Anemia
-
β-thalassemia
major
-
Sickle
cell anemia
-
Aplastic
anemia
-
Severe
anemia of any cause
-
Hypovolemia
due to hemorrhage
-
Blood
loss during surgery
Fresh Frozen Plasma (FFP)
-
Plasma
with anticoagulant preservative.
-
Frozen
immediately at –20°C, shelf-life of 1 year.
-
Contains
high levels of clotting factors.
Indications for FFP
-
Patients
on anticoagulant drug therapy (Coumarin)
-
Antithrombin
deficiency
-
Liver
diseases
-
Vitamin K
deficiency
-
Thrombotic
thrombocytopenic purpura (TTP)
-
Disseminated
intravascular coagulation (DIC)
Platelet Concentrate
-
Obtained
from a single donor or pooled plasma.
-
Alternatively,
obtained through platelet apheresis.
-
Stored at
20°C to 24°C to maintain viability.
-
Shelf-life
of 5 days ensures timely utilization.
-
Platelets
possess ABO antigens but lack Rh antigen expression.
Indications for Platelet
Concentrate
-
Thrombocytopenia
(platelet count <20,000/cu mm)
-
Immune-mediated
-
Secondary
-
Chemotherapy-induced
-
Due to
leukemia
-
Dilutional
-
Abnormal
platelet function
-
DIC
-
Bleeding
disorders
Cryoprecipitate
-
The cold
insoluble portion of plasma that precipitates when FFP is thawed between 1° to
6° C.
-
Contains
concentrated Factor VIII, XIII, vWF, and fibrinogen.
Indications for
Cryoprecipitate
-
Hemophilia
-
Factor
XIII deficiency
-
Von
Willebrand disease
-
Hypofibrinogenemia
Apheresis
-
Process
of collecting anticoagulated whole blood from a donor.
-
Separation
into components, retaining desired components, and returning the rest to the
donor.
-
Collects
various components for transfusion:
-
Platelets
(Platelet apheresis)
-
Leukocytes
-
Plasma
(Plasmapheresis)
-
Peripheral
stem cells
-
Therapeutic
apheresis to remove pathological components like cells, plasma, or plasma
constituents:
-
Thrombotic
thrombocytopenic purpura
-
Goodpasture
syndrome
-
Guillain-Barré
syndrome
Granulocyte Transfusion
-
Used to
combat infections:
-
Neonatal
sepsis
-
Chronic
granulomatous disease
Indications for Granulocyte
Transfusion
-
Agranulocytosis
with a granulocyte count of less than 500/cu mm
Comments
Post a Comment